Improved activation of vital oncogenic signalling pathways (PI3K/AKT, RAS/MAPK and MYC) upstream of ribosome biogenesis constitutes yet another hallmark of HGSC,9 and we hypothesise that inhibiting ribosome biogenesis can offer a successful most cancers therapeutic option.ten Certainly, we have demonstrated encouraging responses Using the ribosomal RNA gene (rDNA) transcription inhibitor https://wernerp887ngx0.ziblogs.com/profile